tiprankstipranks
Trending News
More News >
iTeos Therapeutics (ITOS)
NASDAQ:ITOS
US Market

iTeos Therapeutics (ITOS) Technical Analysis

Compare
189 Followers

Technical Sentiment

Overall Consensus
Sell
3Bullish
6Neutral
13Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
iTeos Therapeutics’s (ITOS) Moving Averages Convergence Divergence (MACD) indicator is 0.23, suggesting iTeos Therapeutics is a Sell.
iTeos Therapeutics’s (ITOS) 20-Day exponential moving average is 6.84, while iTeos Therapeutics’s (ITOS) share price is $6.62, making it a Sell.
iTeos Therapeutics’s (ITOS) 50-Day exponential moving average is 6.82, while iTeos Therapeutics’s (ITOS) share price is $6.62, making it a Sell.

iTeos Therapeutics (ITOS) Pivot Points

May 07, 2025, 10:49 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.31
6.71
6.94
7.34
7.57
7.97
8.20
Fibonacci
6.71
6.95
7.10
7.34
7.58
7.73
7.97
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

iTeos Therapeutics (ITOS) Moving Averages

May 07, 2025, 10:49 PM
Period
Simple
Exponential
MA5
7.26Sell
7.10Sell
MA10
7.22Sell
7.06Sell
MA20
6.59Buy
6.84Sell
MA50
6.66Sell
6.82Sell
MA100
7.14Sell
7.50Sell
MA200
9.62Sell
9.89Sell
iTeos Therapeutics’s (ITOS) 10-Day exponential moving average is 7.06, while iTeos Therapeutics’s (ITOS) share price is $6.62, making it a Sell.
iTeos Therapeutics’s (ITOS) 100-Day exponential moving average is 7.50, while iTeos Therapeutics’s (ITOS) share price is $6.62, making it a Sell.
iTeos Therapeutics’s (ITOS) stock price is $6.62 and iTeos Therapeutics’s (ITOS) 50-day simple moving average is 6.66, creating a Sell signal.
iTeos Therapeutics’s (ITOS) stock price is $6.62 and iTeos Therapeutics’s (ITOS) 100-day simple moving average is 7.14, creating a Sell signal.
iTeos Therapeutics’s (ITOS) stock price is $6.62 and iTeos Therapeutics’s (ITOS) 200-day simple moving average is 9.62, creating a Sell signal.

iTeos Therapeutics (ITOS) Technical Indicators

May 07, 2025, 10:49 PM
Name
Value
Implied Action
RSI (14)
48.15
Neutral
STOCH (9,6)
50.77
Neutral
STOCHRSI (14)
69.98
Neutral
MACD (12,26)
0.23
Sell
ADX (14)
21.96
Neutral
Williams %R
-61.46
Buy
CCI (14)
18.37
Neutral
ATR (14)
0.48
-
Ultimate Oscillator
51.31
Neutral
ROC
11.45
Buy
iTeos Therapeutics’s (ITOS) Relative Strength Index (RSI) is 48.15, creating a Neutral signal.
iTeos Therapeutics’s (ITOS) Trend Strength Indicator (ADX) is 21.96, creating a Neutral signal.
iTeos Therapeutics’s (ITOS) Commodity Channel Index (CCI) is 18.37, creating a Neutral signal.
iTeos Therapeutics’s (ITOS) Price Rate of Change (ROC) is 11.45, creating a Buy signal.

FAQ

Is ITOS a Buy, Hold, or Sell?
Based on ITOS’s technical indicators, ITOS is a Sell.
    What is ITOS’s RSI (14)?
    ITOS’s RSI (14) is 48.15, which suggests ITOS is a Neutral.
      What is ITOS’s MACD?
      ITOS’s MACD is 0.23, which suggests ITOS is a Sell.
        What is ITOS’s 5-day moving average?
        ITOS’s 5-day moving average is 7.26, which suggests ITOS is a Sell.
          What is ITOS’s 20-day moving average?
          ITOS 20-day moving average is 6.59, which suggests ITOS is a Buy.
            What is ITOS’s 50-day moving average?
            ITOS’s 50-day moving average is 6.66, which suggests ITOS is a Sell.
              What is ITOS’s 200-day moving average?
              ITOS’s 200-day moving average is 9.62, which suggests ITOS is a Sell.
                What is ITOS’s Williams % R (14)?
                ITOS’s Williams % R (14) is -61.46, which suggests ITOS is a Buy.
                  What is ITOS’s CCI (14)?
                  ITOS’s CCI (14) is 18.37, which suggests ITOS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis